Picard Medical (PMI) Cost of Revenue (2024 - 2026)

Picard Medical (PMI) has 3 years of Cost of Revenue data on file, last reported at $875000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 10.53% year-over-year to $875000.0; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (up 17.18% YoY), and the FY2025 full-year result was $5.1 million, up 14.23% from the prior year.
• Cost of Revenue for Q1 2026 stood at $875000.0, up from $598000.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.3 million in Q2 2025 and bottomed at $598000.0 in Q4 2025.
• The 3-year median for Cost of Revenue is $1.0 million (2024), against an average of $1.2 million.
• Peak annual rise in Cost of Revenue reached 109.85% in 2025, while the deepest fall reached 15.25% in 2025.
• A 3-year view of Cost of Revenue shows it stood at $700000.0 in 2024, then decreased by 14.57% to $598000.0 in 2025, then surged by 46.32% to $875000.0 in 2026.
• The last three Cost of Revenue figures came in at $875000.0 (Q1 2026), $598000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison